Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
treatment   save search
NeuroBo Pharmaceuticals Completes Enrollment of Part 1 of Its Phase 2a Clinical Trial Evaluating DA-1241 for the Treatment of MASH
Published: 2024-04-01 (Crawled : 12:00) - prnewswire.com
NRBO | $3.325 -3.34% -3.46% 21K twitter stocktwits trandingview |
Health Technology
 | | O: -1.2% H: 0.0% C: -1.46%
da-1241 treatment pharmaceuticals trial
Axsome Therapeutics Initiates ENGAGE Phase 3 Trial of Solriamfetol for the Treatment of Binge Eating Disorder
Published: 2024-04-01 (Crawled : 11:00) - globenewswire.com
AXSM | $67.91 3.33% 3.22% 890K twitter stocktwits trandingview |
Health Technology
 | | O: 0.32% H: 0.0% C: -3.52%
treatment trial therapeutics solriamfetol
Eisai Completes Submission of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease to the U.S. FDA
Published: 2024-03-31 (Crawled : 00:00) - prnewswire.com
BIIB | $194.39 2.03% 1.99% 1.6M twitter stocktwits trandingview |
Health Technology
 | | O: -0.88% H: 0.0% C: 0.0%
leqembi fda disease license treatment alzheimer's application submission
Global Infectious Enteritis Treatment Market Report 2024: A USD$937.7 Million Market by 2034 - Antibiotics Segment Dominates the Market
Published: 2024-03-29 (Crawled : 23:00) - prnewswire.com
ARDX | $6.5 0.93% 0.92% 5.6M twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
SNY | News | $46.32 2.05% 2.01% 3.3M twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
GLAXF | News | $20.2 -14.18% 510 twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
ABT | News | $107.28 1.91% 0.18% 10M twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
GSK | News | $39.75 1.22% 0.0% 1.6M twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
JNJ | News | $147.91 1.49% -0.03% 9.6M twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
SNYNF | News | $92.7 -2.18% 600K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
report million treatment antibiotics global market
FDA Approves Treatments for Anemia in Chronic Kidney Disease, Hepatitis
Published: 2024-03-29 (Crawled : 19:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
ABT | News | $107.28 1.91% 0.18% 10M twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
JNJ | News | $147.91 1.49% -0.03% 9.6M twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
PRGO | News | $30.8 2.87% -1.14% 1.2M twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
SNYNF | News | $92.7 -2.18% 600K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
fda hepatitis kidney anemia
Applied Therapeutics Provides FDA Update on PDUFA Target Action Date for Govorestat for the Treatment of Classic Galactosemia
Published: 2024-03-28 (Crawled : 21:00) - globenewswire.com
APLT A | $4.4 -7.17% -7.73% 2.9M twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
fda update treatment pdufa therapeutics
China's National Medical Products Administration Accepts Astellas and Pfizer's Supplemental Biologics License Application for enfortumab vedotin with KEYTRUDA® (pembrolizumab) for First-Line Treatment of Advanced Bladder Cancer
Published: 2024-03-28 (Crawled : 15:00) - prnewswire.com
ALPMY | $9.47 -1.11% 520K twitter stocktwits trandingview |
Manufacturing
 | | O: 0.82% H: 0.0% C: -2.54%
keytruda license bladder cancer treatment medical application advanced
FibroBiologics Files Patent Application Covering Fibroblast-based Technology for the Potential Treatment of Lupus
Published: 2024-03-28 (Crawled : 13:30) - globenewswire.com
FBLG | $10.01 -9.08% -9.99% 38K twitter stocktwits trandingview |
| | O: -1.87% H: 0.0% C: -6.24%
patent lupus treatment application technology potential
PTC Announces Submission of Sepiapterin MAA for Treatment of PKU to EMA
Published: 2024-03-28 (Crawled : 12:30) - prnewswire.com
PTCT | News S | $25.32 2.55% 2.49% 3.9M twitter stocktwits trandingview |
Health Technology
 | | O: 0.14% H: 1.19% C: -1.32%
treatment ema submission
4DMT Announces Update on Regulatory Interactions and Development Path for 4D-710 for Treatment of Cystic Fibrosis
Published: 2024-03-28 (Crawled : 12:00) - globenewswire.com
FDMT M | $25.29 2.06% 2.02% 630K twitter stocktwits trandingview |
Health Technology
 | | O: -4.77% H: 0.11% C: -6.73%
update treatment fibrosis
Milestone Pharmaceuticals Announces Resubmission of New Drug Application for Etripamil for Treatment in Paroxysmal Supraventricular Tachycardia
Published: 2024-03-28 (Crawled : 11:00) - globenewswire.com
MIST | $1.64 0.61% 0.61% 30K twitter stocktwits trandingview |
Health Technology
 | | O: 4.44% H: 0.0% C: 0.0%
etripamil drug tachycardia resubmission treatment pharmaceuticals application milestone
European Commission Approves Merck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy as Neoadjuvant Treatment, Then Continued as Monotherapy as Adjuvant Treatment, for Resectable Non-Small Cell Lung Cancer at High Risk of Recurrence in Adults
Published: 2024-03-28 (Crawled : 11:00) - biospace.com/
MRK | News | $125.78 0.44% 0.0% 8.4M twitter stocktwits trandingview |
Health Technology
 | | O: 0.18% H: 0.0% C: 0.0%
keytruda lung cancer cell risk plus
Vafseo® approved by the U.S. FDA for the treatment of anemia due to chronic kidney disease in dialysis-dependent adult patients
Published: 2024-03-28 (Crawled : 07:00) - prnewswire.com
TVTX | $5.73 -1.21% -1.22% 950K twitter stocktwits trandingview |
Health Technology
 | | O: 0.91% H: 3.1% C: -0.39%
AKBA | $1.36 -2.16% -2.21% 2.9M twitter stocktwits trandingview |
Health Technology
 | | O: 10.27% H: 0.4% C: -25.91%
vafseo fda disease kidney anemia approved treatment
Akebia Receives FDA Approval of Vafseo® (vadadustat) Tablets for the Treatment of Anemia due to Chronic Kidney Disease in Adult Patients on Dialysis
Published: 2024-03-28 (Crawled : 01:00) - prnewswire.com
AKBA | $1.36 -2.16% -2.21% 2.9M twitter stocktwits trandingview |
Health Technology
 | | O: 10.27% H: 0.4% C: -25.91%
vafseo fda disease kidney anemia approval treatment dialysis
Hoth Therapeutics' Wholly Owned Subsidiary Merveille.ai, Advances AI-Driven Discovery for Obesity Treatment
Published: 2024-03-27 (Crawled : 00:00) - biospace.com/
HOTH | $1.22 3.39% 3.28% 22K twitter stocktwits trandingview |
Health Technology
 | | O: 5.37% H: 0.64% C: -12.1%
obesity treatment wholly
HUTCHMED Announces Savolitinib sNDA Accepted in China for Treatment-Naïve or Previously Treated Patients with Locally Advanced or Metastatic MET Exon 14 NSCLC
Published: 2024-03-28 (Crawled : 00:00) - globenewswire.com
HCM | $16.49 0.8% 0.79% 61K twitter stocktwits trandingview |
Health Technology
 | | O: 0.47% H: 0.71% C: -0.77%
advanced china
Global Particle Therapy Market Analysis and Forecasts, 2023-2033 : Revolutionizing Cancer Treatment, Particle Therapy's Rise in External Beam Radiotherapy
Published: 2024-03-27 (Crawled : 23:00) - prnewswire.com
BSGM | $1.41 -8.44% -9.22% 200K twitter stocktwits trandingview |
Health Technology
 | | O: 3.94% H: 4.19% C: -10.55%
cancer global therapy market
FDA Approves New Treatments for Two Rare Diseases
Published: 2024-03-27 (Crawled : 13:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K twitter stocktwits trandingview |
Health Technology
 | | O: -0.26% H: 0.0% C: 0.0%
PRGO | News | $30.8 2.87% -1.14% 1.2M twitter stocktwits trandingview |
Health Technology
 | | O: 0.84% H: 1.48% C: 1.29%
JNJ | News | $147.91 1.49% -0.03% 9.6M twitter stocktwits trandingview |
Health Technology
 | | O: 0.3% H: 0.0% C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M twitter stocktwits trandingview |
Health Technology
 | | O: 1.48% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M twitter stocktwits trandingview |
Health Technology
 | | O: 1.06% H: 0.0% C: 0.0%
fda rare
Provectus Biopharmaceuticals Announces Exclusive Worldwide License Agreement with University of Miami for Photodynamic Antimicrobial Treatment of Different Eye Infections with Rose Bengal Sodium
Published: 2024-03-27 (Crawled : 12:00) - globenewswire.com
PVCT 4 | $0.195 -15.0% 56K twitter stocktwits trandingview |
Manufacturing
 | | O: -0.91% H: 5.79% C: 2.46%
rose license worldwide treatment eye infections agreement
89bio Receives EMA PRIME Status for Pegozafermin in the Treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH) with Fibrosis and Compensated Cirrhosis
Published: 2024-03-27 (Crawled : 12:00) - globenewswire.com
ETNB | $9.08 2.25% 2.2% 1M twitter stocktwits trandingview |
Health Technology
 | | O: 0.45% H: 3.29% C: 0.53%
metabolic cirrhosis treatment fibrosis prime ema
Gainers vs Losers
67% 33%

Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M twitter stocktwits trandingview |
Finance
EGOX | $0.0515 43.06% 30.1% 330M twitter stocktwits trandingview |

OLB 4 | $0.33 -14.95% 25.53% 840K twitter stocktwits trandingview |
Technology Services
NVFY | $2.77 31.28% 23.83% 33M twitter stocktwits trandingview |
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M twitter stocktwits trandingview |
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M twitter stocktwits trandingview |
Distribution Services
INSG | $3.03 25.21% 20.13% 330K twitter stocktwits trandingview |
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K twitter stocktwits trandingview |
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M twitter stocktwits trandingview |

ASNS | $0.828 21.75% 17.86% 18K twitter stocktwits trandingview |

Your saved searches
Save your searches and get alerts when important news are released.